ArticleFrontiers in global women's health2025
Quality of life and pain severity changes over time in patients with breast cancer who were referred for palliative oncology treatment in Indonesia: a hospital-based cohort study.
Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Understanding quality of life (QOL) and changes in pain severity over time is important to quantify cancer patients' treatment outcomes. However, this information is limited, especially in lower-middle-income countries. This study aimed to prospectively assess QOL, QOL domains, and pain severity over time in patients with advanced breast cancer in Indonesia. Methods: Women with advanced breast cancer ( Results: The descriptive analysis showed that the patients' EORTC QLQ-C15-PAL mean scores for overall QOL and the functional scales (physical and emotional functioning) were fair to good at all assessment points (range: 60-70 points) and substantially better at T0 compared to T1 and T2. In addition, most of the scores for the symptom scales of the EORTC QLQ-C15-PAL indicated lessening symptom burden (<10 points), except for pain and fatigue (20-30 points). At the same time, overall QOL, emotional functioning, fatigue, dyspnea, appetite loss, constipation, and VAS score remained stable over time. Exceptions were found for physical functioning (a medium to large deterioration with scores of -16.5 and -19.8 points, respectively) and insomnia (a medium improvement with a score of -13.4 points), with clinically relevant changes. Conclusions: Our findings from a 6-month longitudinal study show that palliative oncology treatment benefitted patients with advanced breast cancer in this health facility across several symptom scales.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.